Skip to main content

Published locations for Ibrutinib becomes first FDA-approved treatment for chronic GVHD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib becomes first FDA-approved treatment for chronic GVHD

User login

  • Reset your password
  • /content/ibrutinib-becomes-first-fda-approved-treatment-chronic-gvhd
  • /hematologynews/article/143819/cellular-therapy/ibrutinib-becomes-first-fda-approved-treatment
  • /oncologypractice/article/143819/cellular-therapy/ibrutinib-becomes-first-fda-approved-treatment
  • /hematology-oncology/article/143819/cellular-therapy/ibrutinib-becomes-first-fda-approved-treatment